Faisal 14 May 2026Indian pharmaceutical giant Zydus has announced plans to acquire US-based Assertio Holdings in a deal worth nearly $166.4 million, marking a significant expansion of its international presence. The tender offer is expected to begin within five business days of the merger agreement, while the transaction is projected to close during the financial year 2026-27, subject to regulatory approvals and ot4 likes4 comments#healthcare#usindiabusiness#businessnews#pharma#zydus
Jacob Smith13 Apr 2026Europe’s pharmaceutical sector faces pressure as U.S. trade policies under Donald Trump and China’s biotech rise reshape global competition. Declining R&D share and rising tariffs are pushing companies to shift investments, intensifying concerns over Europe’s future role in the global drug industry. #Europe #Pharma #China #USA #TradeWar #Biotech #GlobalEconomy3 likes3 comments#europe#globaleconomy#china#pharma#biotech
Jacob Smith3 Apr 2026Pharma giant Novo Nordisk has said its Wegovy pill demonstrates stronger weight loss results with fewer side effects compared to a rival drug from Eli Lilly. The development intensifies competition in the fast-growing obesity treatment market, which is seeing significant innovation and demand worldwide. #Wegovy #NovoNordisk #EliLilly #Pharma #Health #WeightLoss #MedicalNews #Innovation #BreakingNe4 likes4 comments#weightloss#medicalnews#breakingnews#pharma#health
Jacob Smith3 Apr 2026U.S. President Donald Trump has unveiled sweeping tariff changes, proposing duties of up to 100% on pharmaceutical imports unless companies reduce prices and shift manufacturing to the United States. The policy includes a 120–180 day compliance window and selective relief for allies, reflecting Washington’s push for domestic production amid rising global tensions linked to the Iran conflict. #Dona4 likes4 comments#breakingnews#uspolicy#economy#pharma#globaltrade
Jacob Smith30 Mar 2026AI Drug Deal Insilico Medicine has partnered with pharma giant Eli Lilly to advance AI-discovered drugs, marking a major step in tech-driven healthcare innovation. The collaboration highlights how artificial intelligence is reshaping drug discovery and accelerating medical breakthroughs globally. #AI #Healthcare #Pharma #Innovation #EliLilly #Insilico #Tech5 likes5 comments#insilico#elililly#tech#ai#innovation
Jacob Smith30 Mar 2026Novartis Deal Novartis is planning a $2 billion acquisition of biotech firm Excellergy, betting big on next-generation allergy treatments. The move underscores growing competition and innovation in the global pharmaceutical sector. #Novartis #Biotech #Pharma #Healthcare #Investment #Innovation5 likes5 comments#biotech#novartis#investment#innovation#healthcare
Jacob Smith26 Mar 2026Merck Acquisition 💊 Pharma giant Merck is acquiring Terns Pharmaceuticals for $6.7 billion, signaling strong expansion in biotech innovation and drug development capabilities. #Pharma #Merck #Biotech #Healthcare #BusinessDeal5 likes5 comments#biotech#businessdeal#merck#healthcare#pharma
Jacob Smith25 Mar 2026Biotech firm Abivax is planning to raise funds after releasing key trial data, signaling strong confidence in its pipeline. The company says it is not rushing into a sale, keeping options open amid growing investor interest. #Biotech #Abivax #Healthcare #Investing #Pharma8 likes7 comments#biotech#investing#abivax#healthcare#pharma
Faisal 24 Mar 2026The Indian government has intensified action against the unauthorized sale of GLP-1 weight-loss drugs, tightening nationwide surveillance to prevent misuse. Officials aim to ensure these medicines are distributed only through approved channels, safeguarding public health and regulating access responsibly. #India #Healthcare #WeightLoss #Pharma #DrugRegulation #PublicHealth #Breaking9 likes7 comments#publichealth#weightloss#india#breaking#drugregulation